APOE and Alzheimer disease: To better understand whether APOE4+ women are differentially sensitive to estrogen loss in the postmenopause, we investigated the separate and interactive associations of estrogens, plasma AD biomarkers, and APOE4 carrier status on regional brain volumes in a sample of late midlife postmenopausal women.